These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16611114)
1. Primary and secondary stroke prevention with antiplatelet drugs. Diener HC Curr Pharm Des; 2006; 12(10):1293-7. PubMed ID: 16611114 [TBL] [Abstract][Full Text] [Related]
2. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents and randomized trials. Diener HC Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669 [TBL] [Abstract][Full Text] [Related]
5. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events. Guthrie R Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
8. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Jamieson DG; Parekh A; Ezekowitz MD J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203 [TBL] [Abstract][Full Text] [Related]
9. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
10. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347 [TBL] [Abstract][Full Text] [Related]
12. New insights in antiplatelet therapy for patients with ischemic stroke. Chaturvedi S; Bhattacharya P Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467 [TBL] [Abstract][Full Text] [Related]
13. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900 [TBL] [Abstract][Full Text] [Related]
14. [Secondary prevention with clopidogrel after TIA or stroke]. Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963 [TBL] [Abstract][Full Text] [Related]
15. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke. Lenz T; Wilson A Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264 [TBL] [Abstract][Full Text] [Related]
19. Prevention of ischaemic stroke--antiplatelets. McCabe DJ; Brown MM Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100 [TBL] [Abstract][Full Text] [Related]
20. Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Lenz TL; Hilleman DE Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]